Cardiolife Approved for Commercial Use in the UAE

Cardiolife’s AI-powered ECG interpretation software has received regulatory approval for commercial use in the United Arab Emirates, enabling the company to bring its technology to healthcare providers across the UAE and marking another important step in its international expansion.

The approval enables Cardiolife to support clinicians and healthcare organisations in the UAE with AI-powered tools designed to make ECG and Holter analysis faster, more consistent and more efficient, while keeping clinicians in control of the review and reporting process.

“The UAE is an important and rapidly developing healthcare market, with a strong focus on innovation and digital health,” said Kristin Lied, CEO of Cardiolife. “We are very pleased to have reached this milestone and look forward to working with partners in the region to bring our technology to more clinicians and patients.”

With regulatory approval now secured, Cardiolife will focus on developing local partnerships and supporting the introduction of its technology into clinical practice across the UAE.